Century Therapeutics Inc: Weathering Stock Market Storms with 46.86M Market Cap

Century Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $3.46 on 06/11/24 and a low of $0.34 for the same time frame on 04/09/25.

52-week price history of IPSC Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Century Therapeutics Inc’s current trading price is -84.28% away from its 52-week high, while its distance from the 52-week low is 59.11%. The stock’s price range during the 52-week period has remained between $0.34 and $3.46. In the Healthcare sector, the company’s shares saw a trading volume of around 1.11 million for the day, which was evidently higher than the average daily volume of 0.61 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Century Therapeutics Inc (IPSC) has experienced a quarterly decline of -20.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 46.86M and boasts a workforce of 150 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6458, with a change in price of -0.5680. Similarly, Century Therapeutics Inc recorded 577,587 in trading volume during the last 100 days, posting a change of -51.17%.

Examining IPSC’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IPSC stands at 0.22. Similarly, the long-term debt-to-equity ratio is also 0.20.

IPSC Stock Stochastic Average

As of today, Century Therapeutics Inc’s raw stochastic average for the last 50 days stands at 68.28%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 41.88%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 48.75% and 51.60%, respectively.

IPSC Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -46.15% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -58.17%. Over the past 30 days, the price of IPSC has fallen by 0.42%. And in the last five days, it has fallen by -5.29%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.